
Glenmark Pharma arm to launch breast cancer treatment injection in US market
Glenmark Pharma’s US arm will launch Eribulin Mesylate Injection, a complex generic for breast cancer treatment, in September 2025.

Glenmark Pharma’s US arm will launch Eribulin Mesylate Injection, a complex generic for breast cancer treatment, in September 2025.

On banking, Rahul Arora, CEO of Nirmal Bang Equities pointed out valuation and credit growth challenges. He said large private banks are trading at higher…

The NSE Nifty 50 fell 45 points, or 0.18%, to close at 24,580, while the S&P BSE Sensex dropped 207 points, or 0.26%, to 80,158.…

DEE Development Engineers received a ₹170 crore Letter of Intent from a PSU in the power sector to supply 1,900 MT of critical piping for…

Jain Irrigation will raise these funds in one or more tranches, the statement said.

Before joining IndusInd Bank, Gondhalekar served as country head – group audit at Deutsche Bank India. She has also held leadership positions at L&T Financial…

The IPO comprises a fresh issue of equity shares worth ₹900 crore and an offer for sale by existing shareholders of ₹1,100 crore.

In the 18 trading sessions since its listing on August 6, shares of NSDL have gained in 12 of them and continue to trade above…

The currency was last at 88.0050, up 0.2% from Monday’s (September 1’s) close. It hit an intraday high of 87.9550 on the interbank order-matching system.

The Tata group company has started sending the letters of increment to the employees from late Monday evening, and the increments will be applicable from…